FOSTER CITY, Calif. / Nov 24, 2025 / Business Wire / Gilead Foundation today announced that it has committed over $3 million in grants to expand access to food in communities across the United States. Gilead Foundation Healing Hunger awards will enable 14 regionally focused organizations to meet the unique needs of their communities by improving long-term nutrition access. The funding, distributed through the Gilead Foundation, supports organizations addressing food insecurity in California, North Carolina, New Jersey, Maryland, and Washington, D.C.
The funding focuses on reducing barriers to fresh food in vulnerable communities where food insecurity rates remain highest. Funding supports innovative food sourcing and distribution models, and integrated services to connect families with nutrition education, workforce training, and benefits enrollment.
“There is a deep connection between food security and health,” said Shreya Jani, Senior Vice President of Public Affairs, Gilead Sciences and Board Member, Gilead Foundation. “Food insecurity is linked to a wide range of health risks, including chronic conditions, infectious diseases, and other serious illnesses. Through Gilead Foundation Healing Hunger, we are partnering with organizations that provide education, infrastructure, training and more to make a real impact and improve health outcomes.”
Food insecurity is closely tied to poorer health outcomes, including diabetes, hypertension, obesity, and depression, as well as developmental delays and long-term health issues for children. The Gilead Foundation grants will be used to pilot and scale solutions including mobile pantries, produce recovery efforts, urban farming initiatives, and school-centered distribution programs, with the goal to strengthen local food systems and improve food stability for families.
“The California Association of Food Banks, in partnership with the five Bay Area food banks, is grateful for the Gilead Foundation’s investment in our collaborative sourcing model,” said Stacia Hill Levenfeld, Chief Executive Officer, California Association of Food Banks. “This funding will expand access to culturally relevant food, strengthen local food systems, and improve long-term community health.”
Key Facts:
Grant recipients include:
The Gilead Foundation's investment in Gilead Foundation Healing Hunger is part of its broader commitment to supporting communities where Gilead employees live and work. In 2024, the Foundation contributed $21.5 million to organizations committed to advance programs that promote education, health equity, and community resilience.
About the Gilead Foundation
The Gilead Foundation is a nonprofit organization that works to create a thriving health ecosystem. The Gilead Foundation takes a holistic approach to mitigate the root causes of health inequities by providing resources to organizations that empower people with the skills to be their own best advocate and create systems of support that strengthen communities, classrooms and workplaces.
About Gilead Sciences
Gilead Sciences, Inc. (Nasdaq: GILD) is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness – while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.
Gilead and the Gilead logo are trademarks of Gilead Sciences, Inc., or its related companies.
For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).
| Last Trade: | US$121.22 |
| Daily Change: | -1.40 -1.14 |
| Daily Volume: | 3,697,617 |
| Market Cap: | US$150.310B |
December 06, 2025 December 06, 2025 November 20, 2025 November 18, 2025 | |

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load